Orchestra BioMed Holdings, Inc. Shareholders' Equity
Orchestra BioMed Holdings, Inc. (OBIO) had Shareholders' Equity of $99.75 million as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Balance Sheet › Equity
us-gaap:StockholdersEquity · last filed 2023-05-12
- 2023-03-31: Stockholders' Equity Attributable to Parent $99.75M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $52.53M; Stockholders' Equity Attributable to Parent as first filed -$6.94M.
- 2022-09-30: Stockholders' Equity Attributable to Parent -$6.07M.
- 2022-06-30: Stockholders' Equity Attributable to Parent -$5.25M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2023-03-31 | $99.75M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $52.53M 10-Q · filed 2023-05-12 | -$6.94M 10-K · filed 2023-01-25 |
| 2022-09-30 | -$6.07M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$5.25M 10-Q · filed 2022-11-14 | |
| 2022-03-31 | $78.00K 10-Q · filed 2023-05-12 | -$4.38M 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$19.78M 10-Q · filed 2023-05-12 | -$3.94M 10-K · filed 2022-03-31 |
| 2021-09-30 | -$3.85M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$3.76M 10-Q · filed 2022-11-14 | $5.00M 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$3.67M 10-Q · filed 2022-11-14 | $5.00M 10-Q · filed 2021-05-17 |
| 2020-12-31 | -$3.56M 10-K · filed 2023-01-25 | $5.00M 10-K · filed 2021-03-10 |
| 2020-09-30 | -$3.47M 10-Q/A · filed 2022-03-31 | $5.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $13.54K 10-Q/A · filed 2022-03-31 | $13.54K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |